If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks ...

Sun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...

Indian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...

Indian drug maker Zydus Lifesciences is close to acquiring a US company. The deal is expected to be between $100 to $150 million. This acqu...

Peruvian municipalities in Satipo and Nauta have granted legal rights to native stingless bees. These tiny pollinators are now recognized a...

A viral post by Dr Josh Axe on Instagram is pushing a proactive approach to health, where an “anti-cancer diet” is followed not as a cure, ...

Iran's economy faces severe disruption from U.S. and Israeli strikes. Factories are shut, leading to mass job losses and soaring prices for...

Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...

Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

Cipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue...

The government has directed manufacturers to lower prices of Trastuzumab, Osimertinib, and Durvalumab after exempting them from customs dut...

OPPI indicated that import of Pharma Grade Un-denatured Ethanol used in manufacture of anti-cancer formulations should enjoy exemption/redu...

Panacea Biotec is scaling up production of anti-cancer products with the commissioning of its new facility at Baddi in Himachal Pradesh.